Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVs

Completed

Conditions studied: PORTs/Peripheral IVs Complication Rates

In brief

This study is to collect current information on complications rates of subjects undergoing chemotherapy administration through Ports and peripheral IVs.

Key facts

Study ID

NCT02792764

Run by

C. R. Bard

People needed

300

Starts

2014-02-01

Expected to finish

2015-03-01

Last updated by the study team

2016-06-08

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female, age ≥ 21 years
• Subject is currently undergoing or has had infusional cancer therapy (solid tumor or hematologic) through a Bard PORT with a distally-valved catheter/open-ended catheter or infusion through a PIV
• Subject had a chemotherapy regimen consisting of a vesicant and/or irritant
• Subject has signed an Informed Consent Form (ICF) or has had an ICF signed by the subject's legally authorized representative

You may not qualify if…

• Subject has/had an implanted non Bard PORT

Where it is running

• Quincy Medical Group — Quincy, Illinois, United States
• Willis Knighton Cancer Center — Shreveport, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.